| scholarly article | Q13442814 |
| P2093 | author name string | Jing Liu | |
| Yu Sun | |||
| Hong Shang | |||
| Junjie Xu | |||
| Yongjun Jiang | |||
| Haibo Ding | |||
| Zhenxing Chu | |||
| Tian Tang | |||
| Xiaoxu Han | |||
| Zining Zhang | |||
| Yajing Fu | |||
| P2860 | cites work | Immune activation and inflammation in HIV-1 infection: causes and consequences | Q22252860 |
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells | Q28215003 | ||
| Systemic effects of inflammation on health during chronic HIV infection | Q33577551 | ||
| HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality | Q33618542 | ||
| The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment | Q33813372 | ||
| Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection | Q33947817 | ||
| Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells | Q34059612 | ||
| Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy. | Q34126302 | ||
| T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy | Q34193786 | ||
| Immune activation and HIV persistence: implications for curative approaches to HIV infection | Q34351320 | ||
| CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells | Q34395160 | ||
| Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection | Q34430215 | ||
| Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging | Q34581195 | ||
| Lymphoid tissue structure and HIV-1 infection: life or death for T cells | Q34638477 | ||
| Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors | Q34733986 | ||
| T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women | Q34764361 | ||
| Changes in the risk of death after HIV seroconversion compared with mortality in the general population | Q34791057 | ||
| T cell activation predicts carotid artery stiffness among HIV-infected women | Q35113323 | ||
| CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE | Q35842386 | ||
| CD4+ T-cell depletion in HIV infection: killed by friendly fire? | Q36223837 | ||
| Immunological biomarkers predict HIV-1 viral rebound after treatment interruption | Q36250043 | ||
| Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy | Q36344908 | ||
| Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts | Q36402470 | ||
| Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy | Q36854142 | ||
| Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation | Q36930492 | ||
| Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection | Q37003624 | ||
| CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure | Q37059664 | ||
| Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size | Q37187501 | ||
| Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction | Q38602901 | ||
| Race, Sex, Drug Use, and Progression of Human Immunodeficiency Virus Disease | Q39375985 | ||
| T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment | Q40716958 | ||
| Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment. | Q42252037 | ||
| Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease | Q43582240 | ||
| Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir | Q44790341 | ||
| Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. | Q45930407 | ||
| Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts. | Q45930474 | ||
| A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection | Q46280014 | ||
| CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. | Q50795585 | ||
| Premature age-related comorbidities among HIV-infected persons compared with the general population. | Q51000618 | ||
| Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. | Q51797675 | ||
| Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy. | Q51888711 | ||
| Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. | Q53855050 | ||
| Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy | Q58075270 | ||
| Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease | Q73470103 | ||
| Immune reconstitution in HIV-infected patients | Q79955828 | ||
| Survival and proliferation of CD28- T cells during HIV-1 infection relate to the amplitude of viral replication | Q84142062 | ||
| P433 | issue | 28 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e7430 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | The investigation of CD4+T-cell functions in primary HIV infection with antiretroviral therapy | |
| P478 | volume | 96 |
| Q93164947 | Effects of Early and Delayed Antiretroviral Therapy on Plasma Anti-CD4 Autoreactive IgG and Its Association With CD4+ T-Cell Recovery in Acute HIV-Infected Individuals |
| Q58538219 | Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART |
Search more.